Your browser doesn't support javascript.
loading
Microwave-Assisted Synthesis of 3-Hydroxy-2-oxindoles and Pilot Evaluation of Their Antiglaucomic Activity.
Efremov, Alexander M; Beznos, Olga V; Eremeev, Roman O; Chesnokova, Natalia B; Milaeva, Elena R; Shevtsova, Elena F; Lozinskaya, Natalia A.
Afiliação
  • Efremov AM; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
  • Beznos OV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences (IPAC RAS), Chernogolovka 142432, Russia.
  • Eremeev RO; Helmholtz National Medical Center of Eye Diseases, 14/19 Sadovaya-Chernogryazskaya St., Moscow 105062, Russia.
  • Chesnokova NB; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
  • Milaeva ER; Helmholtz National Medical Center of Eye Diseases, 14/19 Sadovaya-Chernogryazskaya St., Moscow 105062, Russia.
  • Shevtsova EF; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia.
  • Lozinskaya NA; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences (IPAC RAS), Chernogolovka 142432, Russia.
Int J Mol Sci ; 24(6)2023 Mar 07.
Article em En | MEDLINE | ID: mdl-36982181
ABSTRACT
Glaucoma is a widespread neurodegenerative disease for which increased intraocular pressure (IOP) is a primary modifiable risk factor. Recently, we have observed that compounds with oxindole scaffolds are involved in the regulation of intraocular pressure and therefore have potential antiglaucomic activity. In this article, we present an efficient method for obtaining novel 2-oxindole derivatives via microwave-assisted (MW) decarboxylative condensation of substituted isatins with malonic and cyanoacetic acids. Various 3-hydroxy-2-oxindoles were synthesized using MW activation for 5-10 min with high yields (up to 98%). The influence of novel compounds applied in instillations on IOP was studied in vivo on normotensive rabbits. The lead compound was found to reduce the IOP by 5.6 Torr (ΔIOP for the widely used antiglaucomatousic drug timolol 3.5 Torr and for melatonin 2.7 Torr).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Micro-Ondas Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Micro-Ondas Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article